A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in patients at high risk of recurrent cardiovascular events after coronary stent implantation. The team was led by Professors Joo-Yong Hahn, Young Bin Song, and Ki Hong Choi of the Division of Cardiology at Samsung Medical Center, Sungkyunkwan University School of Medicine, together with Professor Yong Hwan Park of Samsung Changwon Hospital.
This article was originally published on MedicalXpress.com
